Company performance
Current Price
as of May 21, 2025$7.27
P/E Ratio
N/A
Market Cap
$2.28B
Description
Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.
Metrics
Overview
- HQBridgewater, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAMRX
- Price$7.27-2.02%
Trading Information
- Market cap$2.28B
- Float45.79%
- Average Daily Volume (1m)2,032,746
- Average Daily Volume (3m)2,068,557
- EPS-$0.04
Company
- Revenue$2.83B
- Rev growth (1yr)5.50%
- Net income$12.20M
- Gross margin36.80%
- EBITDA margin22.68%
- EBITDA$157.72M
- EV$5.30B
- EV/Revenue1.87
- P/EN/A
- P/S0.83
- P/BN/A
- Debt/EquityN/A